C
Capstan Medical
Capstan Medical offers a less invasive approach to heart valve treatment by merging surgical robotics with catheter-based technology and next generation implants, significantly reducing recovery time…
About Capstan Medical
Capstan Medical is a company that is developing solutions for heart valve disease. The company is creating a catheter-based, minimally invasive alternative to traditional open-heart surgery for replacing a patient's heart valve.
Read full description
Capstan Medical's technology combines surgical robotics with catheter-based techniques. This approach includes implants, delivery systems, and integrated robotic navigation capabilities. The company is focused on developing treatments for both mitral and tricuspid valve disease. The company's goal is to provide a less invasive and more effective treatment option for patients with structural heart disease.
Capstan Medical has announced the successful completion of the world's first robotic-catheter mitral valve replacements in human patients. The procedures were performed at the First Affiliated Hospital of Nanjing Medical University in China. The company is located in Santa Cruz, California, and is positioned to access creative talent from nearby Silicon Valley and California Universities.
At a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Santa Cruz, United States
- Employees
- 86
- Open positions
- 9
- Dealroom signal
- 94.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Cardiology and cardiovascular, Surgical Equipment, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Dec 2024 | $110M | $440M | Intuitive Ventures · Yu Galaxy · Gideon Strategic Partners · Eclipse Ventures | ↗ |
| SERIES BOther financing | Aug 2023 | $31M | $126M | Eclipse Ventures · Intuitive Ventures · Puma Venture Capital | ↗ |
Growth signals
Latest recorded traffic for Capstan Medical is 2.1K monthly website visits, down 52.3% over the last three months. Capstan Medical's team grew 16.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Eclipse Ventures
Intuitive Ventures
Puma Venture Capital
Series B and later2 investors entered at this stage
Yu Galaxy
Gideon Strategic Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Capstan Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Capstan Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







